Financial Contrast: TransEnterix (TRXDW) versus Its Competitors

Profitability

This table compares TransEnterix and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TransEnterix -2,149.15% -83.74% -64.94%
TransEnterix Competitors -672.41% -133.75% -59.01%

Earnings & Valuation

This table compares TransEnterix and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
TransEnterix $8.53 million -$154.20 million -0.04
TransEnterix Competitors $59.55 million -$32.15 million 4.12

TransEnterix’s competitors have higher revenue and earnings than TransEnterix. TransEnterix is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

8.2% of TransEnterix shares are owned by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by institutional investors. 3.1% of TransEnterix shares are owned by insiders. Comparatively, 18.1% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

TransEnterix has a beta of 2.56, meaning that its share price is 156% more volatile than the S&P 500. Comparatively, TransEnterix’s competitors have a beta of 1.76, meaning that their average share price is 76% more volatile than the S&P 500.

Summary

TransEnterix competitors beat TransEnterix on 7 of the 9 factors compared.

About TransEnterix

(Get Free Report)

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.